Invest in biosolutions
The UK biosolutions investment landscape: 2025 analysis
The climate crisis is one of humanity's greatest challenges, demanding urgent action and innovative solutions across every sector. At the BIA, we firmly believe that biosolutions, the ingenious application of engineering biology, holds the key to a truly sustainable future.
The BIA provides first-of-its-kind funding and investment analysis into UK biosolutions companies. Our 2025 analysis provides a treasure trove of data that paints a clear picture of the dynamism and potential within the innovative UK biosolutions industry.
Unlocking investment: key data and trends
Scaling for global impact: an industry ready for the next stage
The UK biosolutions ecosystem is looking to mature. The emerging shift from numerous seed deals to fewer, larger later-stage investments signals a sector poised for scale and commercialisation. As Dr Karolina Zapadka of Parkwalk Advisors observes, capital is now concentrating on ventures ready for significant growth. Agriculture and food are leading this charge, attracting over half of all private investment and showcasing the UK's expertise in sustainable practices and novel foods. Public funders like Innovate UK remain crucial, providing vital early support that catalyses private investment.
Parkwalk is proud to be one of the most active investors in the UK Deep Biotech space. This latest analysis by the BIA highlights a maturing and increasingly focused ecosystem, with capital now concentrating on scale-ready ventures.
As the market evolves from broad early-stage seeding to targeted growth funding, we remain committed to supporting the most innovative and high-potential companies shaping the future of biotechnology, life sciences, and healthtech. Since 2009, we have invested over £500m, supporting 180+ university spinouts and will continue to back this vibrant, world-leading sector.
Dr Karolina Zapadka
Investor at Parkwalk Advisors
We welcome the findings of the BIA report and our position as the most active UK investor in terms of deal count into Deep Biotech companies.
This reflects the strengths of the investment opportunities in Scotland as well as our focus on supporting and co-investing in ambitious and innovative companies with scaling potential in the areas that will drive improvement in Scotland’s economic performance.
Jane Martin
Managing Director of Innovation & Investment at Scottish Enterprise
The future is bio-engineered
The impressive growth and maturation of the UK biosolutions sector highlighted in this analysis underscore its immense potential. As these innovative companies continue to scale and attract investment, they are building a more sustainable, healthier future. We encourage policymakers, investors, and the public to engage with the full report and join us in championing this vital biorevolution.